Arecor Therapeutics plc (AREC.L)
GBp 38.0
(0.0%)
GBp 38.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 4.57 Million | 2.4 Million | 1.15 Million | 1.69 Million | 1.89 Million | 747.67 Thousand |
| Cost of Revenue | - | 341 Thousand | - | - | - | - |
| Gross Profit | 4.57 Million | 2.06 Million | 1.15 Million | 1.69 Million | 1.89 Million | 747.67 Thousand |
| Operating Expenses | 13.74 Million | 13.03 Million | 7.13 Million | 5.12 Million | 4.57 Million | 3.6 Million |
| Selling, General and Administrative Expenses | 8.91 Million | 5.55 Million | 2.38 Million | 1.64 Million | 1.6 Million | 1.41 Million |
| Research and Development Expenses | 5.97 Million | 8.61 Million | 5.38 Million | 3.93 Million | 3.56 Million | 3.08 Million |
| Other Expenses | -1.14 Million | -1.13 Million | -640 Thousand | -452.45 Thousand | - | -898.33 Thousand |
| Cost and Expenses | 13.74 Million | 13.03 Million | 7.13 Million | 5.12 Million | 4.57 Million | 3.6 Million |
| Operating Income | -9.17 Million | -10.63 Million | -5.97 Million | -3.42 Million | -2.68 Million | -2.85 Million |
| Interest Expense | 15 Thousand | 26 Thousand | 22 Thousand | 81.99 Thousand | 3662.00 | 23.97 Thousand |
| Income Tax Expense | -347 Thousand | -1.28 Million | -776 Thousand | -759.96 Thousand | 502.28 Thousand | -435.09 Thousand |
| Earnings before Tax | -8.9 Million | -10.54 Million | -6.94 Million | -3.51 Million | -2.69 Million | -2.87 Million |
| Net Income | -8.55 Million | -9.26 Million | -6.16 Million | -2.75 Million | -2.18 Million | -2.43 Million |
| Earnings Per Share Basic | -0.28 | -0.32 | -0.27 | -0.10 | -0.14 | -0.09 |
| Earnings Per Share Diluted | -0.28 | -0.32 | -0.27 | -0.10 | -0.14 | -0.09 |
| Weighted Average Shares Outstanding | 30.62 Million | 28.93 Million | 23.03 Million | 27.68 Million | 15.76 Million | 27.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.62 Million | 28.93 Million | 23.03 Million | 27.68 Million | 15.76 Million | 27.68 Million |
| Gross Margin | 1.00 | 0.86 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -1.83 | -4.23 | -5.43 | -1.92 | -1.38 | -3.58 |
| Profit Margin | -1.87 | -3.85 | -5.33 | -1.62 | -1.16 | -3.26 |
| EBITDA | -8.39 Million | -10.06 Million | -6.26 Million | -3.25 Million | -2.61 Million | -2.67 Million |
| Earnings Before Tax Margin | -2.01 | -4.42 | -5.16 | -2.02 | -1.42 | -3.82 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 997.5 Thousand | 997.5 Thousand | 4.57 Million | 1.45 Million | 1.45 Million | 1.66 Million |
| Cost of Revenue | 226 Thousand | - | 496 Thousand | 195 Thousand | - | 301 Thousand |
| Gross Profit | 771.5 Thousand | 997.5 Thousand | 4.07 Million | 1.25 Million | 1.45 Million | 1.36 Million |
| Operating Expenses | 3.41 Million | 3.41 Million | 14.25 Million | 3.56 Million | 3.55 Million | 6.93 Million |
| Selling, General and Administrative Expenses | 2.39 Million | 2.39 Million | - | 2.26 Million | 2.26 Million | 4.07 Million |
| Research and Development Expenses | 1.04 Million | 1.04 Million | - | 1.55 Million | 1.55 Million | 2.85 Million |
| Other Expenses | -19.5 Thousand | -19.5 Thousand | 5000.00 | -266.5 Thousand | - | - |
| Cost and Expenses | 3.41 Million | 3.41 Million | 14.75 Million | 3.56 Million | 3.55 Million | 7.23 Million |
| Operating Income | -2.41 Million | -2.41 Million | -10.18 Million | -2.11 Million | -2.11 Million | -5.56 Million |
| Interest Expense | - | - | 15 Thousand | 5000.00 | - | 10 Thousand |
| Income Tax Expense | 75.5 Thousand | 75.5 Thousand | -347 Thousand | 37 Thousand | 37 Thousand | -273 Thousand |
| Earnings before Tax | -2.39 Million | -2.39 Million | -8.9 Million | -2.04 Million | -2.04 Million | -4.8 Million |
| Net Income | -2.32 Million | -2.32 Million | -8.55 Million | -2.01 Million | -2.01 Million | -4.52 Million |
| Earnings Per Share Basic | -0.08 | -0.08 | - | -0.07 | -0.07 | -0.15 |
| Earnings Per Share Diluted | -0.08 | -0.08 | - | -0.07 | -0.07 | -0.15 |
| Weighted Average Shares Outstanding | 30.62 Million | 30.62 Million | 30.62 Million | 30.62 Million | 30.62 Million | 30.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.62 Million | 30.62 Million | 30.62 Million | 30.62 Million | 30.62 Million | 30.61 Million |
| Gross Margin | 0.77 | 1.00 | 0.89 | 0.87 | 1.00 | 0.82 |
| EBIT Margin | -2.31 | -2.31 | - | -1.40 | -1.38 | -3.15 |
| Profit Margin | -2.33 | -2.33 | -1.87 | -1.39 | -1.39 | -2.71 |
| EBITDA | -2.3 Million | -2.3 Million | - | -2.03 Million | -2.01 Million | -5.26 Million |
| Earnings Before Tax Margin | -2.42 | -2.42 | -2.23 | -1.45 | -1.45 | -3.33 |
WVFC
5085
CAGU
ARYX
WOSSF
600679